NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development30,255.89220,439.99418,533.36342,908.566
Selling General and Administrative10,914.2699,750.7027,576.25611,961.865
Non Recurring----
Others----
Total Operating Expenses41,170.16130,190.69626,109.61954,870.431
Operating Income or Loss-41,170.161-30,190.696-26,109.619-54,870.431
Income from Continuing Operations
Total Other Income/Expenses Net270.682-854.676-972.013-2,031.008
Earnings Before Interest and Taxes-41,170.161-30,190.696-26,109.619-54,870.431
Interest Expense-614.264-1,029.734-1,053.07-2,049.735
Income Before Tax-40,899.479-31,045.372-27,081.632-56,901.439
Income Tax Expense-9,376.272---
Minority Interest----
Net Income From Continuing Ops-31,523.207-31,045.372-27,081.632-56,901.439
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-31,523.207-31,045.372-27,081.632-56,901.439
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-31,523.207-31,045.372-27,081.632-56,901.439